Developer docs
API playgroundTry for free, no card

Search company profiles

NU-RISE

Full company profile

uuid0004fx3

Namestring
NU-RISE
Legal namestring
NU-RISE S.A.
Websiteurl
nu-rise.com
Company typeenum
Private
Founded yearint
2015
Short descriptiontext

NU-RISE S.A. is a Portuguese medical device company that develops the FDA-cleared PRO-DOSE system and NR-01 hardware for real-time radiation monitoring and in vivo dosimetry in HDR brachytherapy, serving radiotherapy clinics, cancer centers, and hospitals worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersÍlhavo, Portugal
HQ citystring
Ílhavo
HQ countrystring
Portugal
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiation dosimetry, HDR brachytherapy verification, radiotherapy quality assurance, medical radiation sensors, in vivo dosimetry
Industry3 codes
PRIMARYHLACALAH
Radiation Dose Management & Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYEUAKAIAH
Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)
SECONDARYHLAIAGAJ
Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine)
Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine
NAICS code1 code
  • Irradiation Apparatus Manufacturing334517
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Radiotherapy Medical Devices
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1PRO-DOSE Medical Device Sales
TypeHardware Sales
Description

Sale of FDA-cleared PRO-DOSE hardware systems to radiotherapy clinics, hospitals, and cancer treatment centers for real-time radiation monitoring and treatment verification.

nu-rise.com
2OEM / Commercial Partnerships
TypeLicensing Royalties
Description

Partnerships with medical device companies for OEM integration or commercial distribution of the PRO-DOSE technology.

nu-rise.com
3Clinical Implementation Services
TypeProfessional Services
Description

Professional services for workflow integration, training, and ongoing support for clinical implementation of the PRO-DOSE system.

nu-rise.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

NU-RISE develops and sells the FDA-cleared PRO-DOSE System, a medical device for real-time radiation monitoring, in vivo dosimetry, and treatment verification in radiotherapy. The system pairs the PRO-DOSE software platform with the NR-01 hardware device to enable direct measurement of radiation dose delivered to patient tissue during treatment, with a specific focus on HDR brachytherapy quality assurance. The company targets radiotherapy clinics, cancer treatment centers, and hospitals, and also pursues OEM and commercial partnerships for broader distribution.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Reduced treatment sessions while maintaining treatment precision
+1 more record
Product and service2 records
1PRO-DOSE System
CategoryRadiotherapy treatment verification system
Description

FDA-cleared in vivo dosimetry and treatment verification system for HDR brachytherapy quality assurance, enabling real-time monitoring of radiation delivery to improve safety and precision while reducing treatment sessions. Targeted at radiotherapy clinics, cancer treatment centers, and hospitals.

2NR-01 Device
CategoryRadiation dosimetry hardware
Description

Hardware device used in conjunction with the PRO-DOSE system for radiation dosimetry and treatment verification applications in radiotherapy.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Peers10 records
TypeDirect peer
Description

Designs QA phantoms and software for radiation therapy and brachytherapy. Overlaps with NU-RISE in brachytherapy-specific QA and treatment verification.

TypeBroad incumbent
Description

Global leader in radiotherapy treatment delivery systems (linacs, brachytherapy afterloaders) and oncology software. Indirectly competing by integrating QA into its treatment ecosystem.

TypeBroad incumbent
Description

Major radiotherapy systems provider (linacs, brachytherapy solutions, Gamma Knife). Competes broadly in the radiation oncology value chain and shapes QA purchasing decisions.

TypeDirect peer
Description

US-based developer of QA instruments and phantoms for radiation therapy, including patient-specific QA tools. Directly comparable as a mid-sized specialist in radiotherapy QA hardware.

TypeBroad incumbent
Description

Developer of CyberKnife and TomoTherapy systems for radiation therapy. Broad incumbent whose installed base creates demand for compatible QA/dosimetry products such as those offered by NU-RISE.

TypeEmerging player
Description

Specialist in patient-specific QA for radiotherapy, with 3D-printed phantoms and dosimetry verification. Emerging niche player addressing similar safety/verification use cases in radiation oncology.

TypeDirect peer
Description

Long-established manufacturer of dosimetry equipment and detectors for radiation therapy and diagnostic radiology. Competes in patient QA detectors and in vivo dosimetry used during radiotherapy.

TypeDirect peer
Description

Leading provider of patient-specific QA solutions for radiation oncology, including in vivo dosimetry and 3D QA. Closest direct competitor in radiotherapy patient QA, overlapping directly with PRO-DOSE's clinical workflow.

TypeBroad incumbent
Description

Parent of Sun Nuclear and broader radiation detection/dosimetry company spanning medical, industrial, and nuclear markets. Sets competitive context through its medical division while offering capital and scale.

TypeDirect peer
Description

Specializes in dosimetry and QA solutions for radiotherapy, including in vivo dosimetry systems (e.g., myQA). Directly competes with PRO-DOSE in radiation delivery verification and QA.

Market position
Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NU-RISE

Radiotherapy Medical Devicesnu-rise.com

NU-RISE S.A. is a Portuguese medical device company that develops the FDA-cleared PRO-DOSE system and NR-01 hardware for real-time radiation monitoring and in vivo dosimetry in HDR brachytherapy, serving radiotherapy clinics, cancer centers, and hospitals worldwide.

NU-RISE firmographics

Firmographics
Name
NU-RISE
Legal name
NU-RISE S.A.
Website
https://nu-rise.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
NU-RISE S.A. is a Portuguese medical device company that develops the FDA-cleared PRO-DOSE system and NR-01 hardware for real-time radiation monitoring and in vivo dosimetry in HDR brachytherapy, serving radiotherapy clinics, cancer centers, and hospitals worldwide.
Ownership category
akta.pro rank

NU-RISE industry classification

Industry
Product category
Radiotherapy Medical Devices
NAICS
Irradiation Apparatus Manufacturing (334517)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACALAH
Radiation Dose Management & Analytics
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYEUAKAIAH
Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs)
Energy, Utilities & Environment/Nuclear Energy/Nuclear Materials, Radiation Services & Isotopes (Medical/Industrial)
SECONDARYHLAIAGAJ
Radiation Safety, Dosimetry & Regulatory Compliance (Nuclear Medicine)
Healthcare & Life Sciences/Pharmaceuticals/Radiopharmaceuticals & Nuclear Medicine

Keywords

  • Radiation dosimetry
  • HDR brachytherapy verification
  • Radiotherapy quality assurance
  • Medical radiation sensors
  • In vivo dosimetry

Where NU-RISE is headquartered

Location

Headquarters

HQ city
Ílhavo
HQ country
Portugal
HQ region
Europe

Offices1 record

Markets served

NU-RISE business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. PRO-DOSE Medical Device Sales: Sale of FDA-cleared PRO-DOSE hardware systems to radiotherapy clinics, hospitals, and cancer treatment centers for real-time radiation monitoring and treatment verification.
  2. OEM / Commercial Partnerships: Partnerships with medical device companies for OEM integration or commercial distribution of the PRO-DOSE technology.
  3. Clinical Implementation Services: Professional services for workflow integration, training, and ongoing support for clinical implementation of the PRO-DOSE system.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

NU-RISE product offering

Product offering

Core offering

NU-RISE develops and sells the FDA-cleared PRO-DOSE System, a medical device for real-time radiation monitoring, in vivo dosimetry, and treatment verification in radiotherapy. The system pairs the PRO-DOSE software platform with the NR-01 hardware device to enable direct measurement of radiation dose delivered to patient tissue during treatment, with a specific focus on HDR brachytherapy quality assurance. The company targets radiotherapy clinics, cancer treatment centers, and hospitals, and also pursues OEM and commercial partnerships for broader distribution.

Differentiator

Problem solved

Functional benefit

Products and services

  • PRO-DOSE System FDA-cleared in vivo dosimetry and treatment verification system for HDR brachytherapy quality assurance, enabling real-time monitoring of radiation delivery to improve safety and precision while reducing treatment sessions. Targeted at radiotherapy clinics, cancer treatment centers, and hospitals.
  • NR-01 Device Hardware device used in conjunction with the PRO-DOSE system for radiation dosimetry and treatment verification applications in radiotherapy.

Quantifiable outcome

  • Reduced treatment sessions while maintaining treatment precision
  • +1 more outcomes

Companies that use NU-RISE

Customer profile

Segments1 record

Ideal customer profiles1 record

NU-RISE technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

NU-RISE partnerships and signals

Strategic signal

Scale indicators3 records

NU-RISE competitors and assessment

Company assessment

Direct peers

  • Modus Medical Devices: Designs QA phantoms and software for radiation therapy and brachytherapy. Overlaps with NU-RISE in brachytherapy-specific QA and treatment verification.
  • Standard Imaging: US-based developer of QA instruments and phantoms for radiation therapy, including patient-specific QA tools. Directly comparable as a mid-sized specialist in radiotherapy QA hardware.
  • PTW Freiburg: Long-established manufacturer of dosimetry equipment and detectors for radiation therapy and diagnostic radiology. Competes in patient QA detectors and in vivo dosimetry used during radiotherapy.
  • Sun Nuclear (Mirion Technologies): Leading provider of patient-specific QA solutions for radiation oncology, including in vivo dosimetry and 3D QA. Closest direct competitor in radiotherapy patient QA, overlapping directly with PRO-DOSE's clinical workflow.
  • IBA Dosimetry: Specializes in dosimetry and QA solutions for radiotherapy, including in vivo dosimetry systems (e.g., myQA). Directly competes with PRO-DOSE in radiation delivery verification and QA.

Broad incumbents

  • Varian (Siemens Healthineers): Global leader in radiotherapy treatment delivery systems (linacs, brachytherapy afterloaders) and oncology software. Indirectly competing by integrating QA into its treatment ecosystem.
  • Elekta: Major radiotherapy systems provider (linacs, brachytherapy solutions, Gamma Knife). Competes broadly in the radiation oncology value chain and shapes QA purchasing decisions.
  • Accuray: Developer of CyberKnife and TomoTherapy systems for radiation therapy. Broad incumbent whose installed base creates demand for compatible QA/dosimetry products such as those offered by NU-RISE.
  • Mirion Technologies: Parent of Sun Nuclear and broader radiation detection/dosimetry company spanning medical, industrial, and nuclear markets. Sets competitive context through its medical division while offering capital and scale.

Emerging players

  • RTsafe: Specialist in patient-specific QA for radiotherapy, with 3D-printed phantoms and dosimetry verification. Emerging niche player addressing similar safety/verification use cases in radiation oncology.

Market position

Customer concentration

NU-RISE social profiles

Digital presence

NU-RISE compliance and trust

Trust signal

Compliance1 record

NU-RISE financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NU-RISE leadership team

Management profile

Number of profiles

Profiles2 records

NU-RISE funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NU-RISE M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NU-RISE

What does NU-RISE do?

NU-RISE develops and sells the FDA-cleared PRO-DOSE System, a medical device for real-time radiation monitoring, in vivo dosimetry, and treatment verification in radiotherapy. The system pairs the PRO-DOSE software platform with the NR-01 hardware device to enable direct measurement of radiation dose delivered to patient tissue during treatment, with a specific focus on HDR brachytherapy quality assurance. The company targets radiotherapy clinics, cancer treatment centers, and hospitals, and also pursues OEM and commercial partnerships for broader distribution.

Is NU-RISE a public or private company?

NU-RISE is a private company. It is classified as venture growth investor backed and is currently operating.

When was NU-RISE founded?

NU-RISE was founded in 2015. It employs 1 to 10 people.

Where is NU-RISE based?

NU-RISE is headquartered in Ílhavo, Portugal, in the Europe region.

How does NU-RISE make money?

Three revenue lines are on record. PRO-DOSE Medical Device Sales are the primary driver. The others are OEM / Commercial Partnerships and clinical Implementation Services.

Who are NU-RISE's main competitors?

Direct peers on record are Modus Medical Devices, Standard Imaging, PTW Freiburg, Sun Nuclear (Mirion Technologies) and IBA Dosimetry. Broad incumbents are Varian (Siemens Healthineers), Elekta, Accuray and Mirion Technologies. RTsafe is listed as an emerging player.

Does NU-RISE have an API?

No public API is recorded for NU-RISE.

What industry is NU-RISE in?

NU-RISE's product category is Radiotherapy Medical Devices. Its primary akta.pro industry code is HLACALAH, Radiation Dose Management & Analytics, with a secondary code of EUAKAIAH, Radiation Measurement, Dosimetry & Monitoring Services (Personal/environmental dosimetry, calibration labs). Its NAICS code is 334517 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales